Pfizer Canada has received approval from Health Canada for its adeno-associated ... therapy for people living with haemophilia B in the form of gene therapy.” In December 2023, Pfizer received ...

The approval of ZORYVE foam by Health Canada marks the second approval for ... discussed in the “Risk Factors” section of our Form 10-K filed with the U.S. Securities and Exchange Commission ...

Atopic dermatitis (AD), an inflammatory skin condition, is the most common form of eczema and is estimated ... to significant emotional and mental health challenges. A topical JAK inhibitor ...

Health Canada's approval is based on data from the Phase 3 clinical trial ... those risks and uncertainties described under the heading 'Risk Factors' in Moderna's Annual Report on Form 10-K for the ...

The Notice of Compliance authorization of DAYBUE makes it the first and only drug approved in Canada for the treatment of Rett syndrome. “Health Canada’s authorization of DAYBUE is a ...

Targets the reduction in CABG-related bleeding severity due to the blood thinning drug, ticagrelor – a major unmet medical need in heart attack ...

FutureCeuticals, Inc. announced today the successful approval of mobility and joint health claims for Promentum™ Calcium Fructoborate in Canada.

Atopic dermatitis (AD), an inflammatory skin condition, is the most common form of eczema and is estimated to impact ... Not surprisingly, atopic dermatitis can lead to significant emotional and ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health ... approval of trofinetide in jurisdictions outside the United States and Canada, our ability ...